Standardizing Long COVID Definitions Essential

Long COVID has emerged as a significant concern affecting millions globally, yet defining the condition has proven to be a complex challenge. A study from UCLA published on August 12, 2025, in JAMA Network Open, highlights the substantial discrepancies in how long COVID is defined across various studies, leading to widely varying estimates of its prevalence.

The Ambiguity of Long COVID Definitions

Despite the extensive research conducted on long COVID, the medical community continues to grapple with a clear and uniform definition of the condition. This lack of standardization contributes to varying estimates of the number of individuals affected. The study's lead, Lauren Wisk, Assistant Professor of Medicine at UCLA, states, “The findings highlight the need for a standard definition for long COVID. Up to one third of the variation in the published studies may stem from the fact that they use different definitions for long COVID.”

Study Overview

The UCLA study utilized data taken from 4,700 U.S. patients within the INSPIRE cohort. Researchers applied five distinct definitions of long COVID stemming from studies conducted in various locales: the United States, United Kingdom, Netherlands, Sweden, and Puerto Rico. Remarkably, the estimated prevalence of long COVID varied from 15% to 42%, depending on the definition applied, reflecting significant discrepancies in identifying cases among the same patient group.

Challenges in Diagnosis and Research

The discrepancies in definitions not only impede the diagnosis and treatment of long COVID but also complicate the broader research landscape. The study revealed that the published definitions possess only moderate sensitivity—the capacity to correctly identify affected individuals—relative to participants' self-reported experiences of long COVID. Although these definitions exhibited better specificity, none reached an ideal standard for optimal identification.

“If every study on long COVID uses a different definition for identifying who has it, the scientific conclusions become harder to compare across studies and may lead to delays in our understanding of it,” claimed Dr. Joann Elmore, Professor of Medicine at UCLA and senior author of the study.

Implications of Non-Standardization

The variation in long COVID definitions may result in classified cases that either miss legitimate instances of long COVID or improperly label patients who do not meet the condition's criteria. This lack of consistency is especially troubling as it affects actual patient care and treatment outcomes.

Dr. Elmore posits, “Without a clinically usable and standardized research definition of long COVID, it's like every study is using a different measuring stick. That makes it hard to compare results, develop treatments, or track progress. Without a shared definition, we risk mislabeling patients and misguiding care. This is more than an academic issue—it affects real people.”

Study Limitations

Despite its insights, the study had notable limitations, including:

• Recall Bias: Potential discrepancies in participant responses.
• Demographic Factors: Unexamined participant demographics that could influence prevalence results.
• Limited Definitions: Analysis based solely on five published definitions, which may not encompass all potential cases of long COVID.

Conclusion

As the challenge of defining long COVID persists, it is vital for researchers and clinicians to adopt a more uniform standard to improve diagnostic accuracy and patient care. The study manifests the crucial need for ongoing discussions and collaboration to establish a standardized definition, enhancing the future of long COVID research and treatment.

References

Brought to you by various studies, including:

• UCLA Study on Long COVID Definitions, JAMA Network Open
• Additional readings on public health and disease definitions.

For more information, visit Medical Xpress.